Research Site

Torreón 27000

2 studies enrolling now · 9 studies all time

What they study most

Cardiovascular Disease, Diabetes Mellitus, Type 2, Heart Failure and Impaired Kidney Function, IgAN, Immunoglobulin A Nephropathy, LN, Lupus Nephritis, Non-Small-Cell Lung Carcinoma, Nonalcoholic Steatohepatitis, Type 1 Diabetes Mellitus, Type 2 Diabetes

Studies at this site

• A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event — Recruiting now
• Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function — Recruiting now
• A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis — Completed
• Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) — Stopped early
• Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes — Completed
• Iressa Versus Docetaxel (Taxotere) — Completed
• GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus — Stopped early
• GALLANT 6 Tesaglitazar vs. Pioglitazone — Stopped early
• G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study) — Stopped early